{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:31:07Z","timestamp":1762864267499},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":8194,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1023\/a:1008228529397","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T13:47:34Z","timestamp":1040564854000},"page":"893-897","source":"Crossref","is-referenced-by-count":20,"title":["Preliminary report of an intensified, short duration chemotherapy protocol for the treatment of pediatric non-Hodgkin's lymphoma in India"],"prefix":"10.1016","volume":"8","author":[{"given":"S.","family":"Advani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Adde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Naresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Kurkure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.N.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Venzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Margrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008228529397_bb0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JCO.1991.9.1.123","article-title":"High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children","volume":"9","author":"Patte","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0010","first-page":"359","article-title":"Non-Hodgkin\u2019s lymphomas of childhood and adolescence: Results of a treatment stratified for biological subtypes and stage","volume":"13","author":"Reiter","year":"1995","journal-title":"A report of the Berlin-Frankfurt-M\u016bnster group. J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JCO.1991.9.1.133","article-title":"HiC-COM: A 2 month intensive chemotherapy regimen for children with stage III and IV Burkitt\u2019s lymphoma and B-cell acute lymphoblastic leukemia","volume":"9","author":"Schwenn","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0025","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1182\/blood.V80.10.2471.2471","article-title":"Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group","volume":"80","author":"Reiter","year":"1992","journal-title":"Blood"},{"key":"10.1023\/A:1008228529397_bib0010","series-title":"Principles and Practice of Pediatric Oncology, 3rd ed","first-page":"1395","article-title":"Pediatric oncology in countries with limited resources","author":"Magrath","year":"1997"},{"key":"10.1023\/A:1008228529397_bb0030","first-page":"559","article-title":"Childhood non-Hodgkin\u2019s lympho","volume":"308","author":"Anderson","year":"1983","journal-title":"The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2L2). N Engl J Med"},{"key":"10.1023\/A:1008228529397_bb0035","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1200\/JCO.1993.11.6.1024","article-title":"Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin\u2019s lymphoma: A report of CCG-551 from the Childrens Cancer Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.1988.6.1.26","article-title":"LL in children\u2014randomized trial comparing LSA2L2 with the A-COP+ regimen: A Pediatric Oncology Group study","volume":"6","author":"Hvizdala","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0045","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood.V63.5.1102.1102","article-title":"An effective therapy for both undifferentiated (including Burkitt\u2019s) lymphomas and lymphoblastic lymphomas in children and young adults","volume":"63","author":"Magrath","year":"1984","journal-title":"Blood"},{"key":"10.1023\/A:1008228529397_bb0050","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced stage Burkitt\u2019s lymphoma and B-cell, (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0055","first-page":"20","article-title":"Childhood non-Hodgkin\u2019s lymphoma in Egypt: Preliminary results of treatment with a new ifosfamide-containing regimen","volume":"24S","author":"Gad-El-Mawia","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1023\/A:1008228529397_bb0060","first-page":"202","article-title":"Non-Hodgkin\u2019s lymphoma in children: Clinical, histological and treatment analysis","volume":"24","author":"Gopal","year":"1987","journal-title":"Ind J Cancer"},{"key":"10.1023\/A:1008228529397_bb0065","first-page":"150","article-title":"Hepatitis B viral infection in ALL","volume":"13","author":"Nag","year":"1995","journal-title":"Ind J Haem Bld Trans"},{"key":"10.1023\/A:1008228529397_bb0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/bjc.1984.78","article-title":"Abdominal Burkitt-type lymphomas in Algeria","volume":"49","author":"Ladjadj","year":"1984","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008228529397_bb0075","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.1986.4.8.1219","article-title":"Improved survival rate in children with stages III and IV B cell non-Hodgkin\u2019s lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society","volume":"4","author":"Patte","year":"1986","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008228529397_bb0080","first-page":"3","article-title":"United Kingdom children\u2019s cancer study group (UKCCSG) experience with the French SFOP intensive regimen for advanced B LL","volume":"21","author":"Pinkerton","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"10.1023\/A:1008228529397_bb0085","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mpo.2950200204","article-title":"Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B cell (lymphoblastic) lymphoma","volume":"10","author":"Patte","year":"1992","journal-title":"Med Pediatr Oncol"},{"key":"10.1023\/A:1008228529397_bb0090","first-page":"85","article-title":"Results of MCP841 ALL protocol for patients with LLs\u2014Cancer Institute experience","volume":"17","author":"Kalaichelvi","year":"1996","journal-title":"Ind J Med Pediatr Oncol"},{"key":"10.1023\/A:1008228529397_bib0015","unstructured":"Naresh K, Bhatia K, Venkatesh H et al. The majority of primary LLs express p53 Blood 1995; SI 10: 340 (Abstr)."}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419639499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419639499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/8\/9\/893\/19481240\/8-9-893.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T02:11:11Z","timestamp":1582251071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419639499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["S0923753419639499"],"URL":"https:\/\/doi.org\/10.1023\/a:1008228529397","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}